The Michael J. Fox Foundation for Parkinson's Research (MJFF) was founded in 2000 with one clear objective: accelerating meaningful therapeutic advances and, ultimately, a cure for Parkinson's disease (PD). The Foundation applies extraordinary scientific, business and media assets to this singular focus—thus creating a unique and dynamic organization. Since inception, MJFF has quickly grown into the largest global funder of Parkinson's disease research outside the U. S. federal government, having funded over $375 million in research projects in both academic and industry labs worldwide.
We believe that to find a cure for PD as quickly as possible, our capital needs to push research forward today—we therefore deliberately have no endowment or reserve. We instead start our fundraising from zero each year and seek to deploy funds raised as quickly and wisely as possible. MJFF raises over $60 million annually. Today, the Foundation has approximately 80 full-time employees who are based in New York City.